Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - NEUROCRINE BIOSCIENCES INCFinancial_Report.xls
EX-31.2 - EX-31.2 - NEUROCRINE BIOSCIENCES INCd899476dex312.htm
EX-31.1 - EX-31.1 - NEUROCRINE BIOSCIENCES INCd899476dex311.htm
EX-10.1 - EX-10.1 - NEUROCRINE BIOSCIENCES INCd899476dex101.htm
10-Q - FORM 10-Q - NEUROCRINE BIOSCIENCES INCd899476d10q.htm

Exhibit 32

CERTIFICATIONS OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Neurocrine Biosciences, Inc. (Company) on Form 10-Q for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (Report), I, Kevin C. Gorman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934; and

 

(2) That information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

April 30, 2015

    By:  

/s/ Kevin C. Gorman

    Name:   Kevin C. Gorman
    Title:   President and Chief Executive Officer

In connection with the Quarterly Report of Neurocrine Biosciences, Inc. (Company) on Form 10-Q for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (Report), I, Timothy P. Coughlin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934; and

 

(2) That information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

April 30, 2015

    By:  

/s/ Timothy P. Coughlin

    Name:   Timothy P. Coughlin
  .   Title:   Chief Financial Officer